Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FH5DP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,886
Award facts
- Contract value 100% obligated
- $13,886.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,886.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, represents a specific fulfillment under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA valued at $499.999 billion and valid through November 2026. The award carries no set-aside designation, allowing the vendor to compete directly in the federal procurement marketplace.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, serving military health facilities nationwide with an extensive portfolio including branded and generic prescription drugs, biologics, and medical consumables. Nexplanon implants, a subdermal contraceptive device, represent one of the specialized pharmaceutical products the company routinely delivers to Department of Defense healthcare sites. The company's SPE2DB program contract with the DLA enables the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical support across military medical facilities, positioning DMS Pharmaceutical Group as a key distributor of prescription medications and pharmacy services to federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FH5DP?
SPE2DB25FH5DP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FH5DP worth?
The government has obligated $13,886 on SPE2DB25FH5DP.
Is contract SPE2DB25FH5DP an order under another contract?
Yes. SPE2DB25FH5DP is a delivery order under SPE2DB22D9207, an indefinite delivery contract.
Was contract SPE2DB25FH5DP competed?
The extent of competition for SPE2DB25FH5DP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award